These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32062879)

  • 1. [The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].
    Wang ZM; Song Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):95-99. PubMed ID: 32062879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer].
    Fu MJ; Zhou JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):87-91. PubMed ID: 32062877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent clinical trials of immunotherapy in non-small-cell lung cancer.
    Gkolfinopoulos S; Mountzios G
    Immunotherapy; 2019 Apr; 11(6):461-466. PubMed ID: 30860438
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
    Santana-Davila R; Chow LQ
    Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
    [No Abstract]   [Full Text] [Related]  

  • 5. Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors.
    Lu S; Yu Y; Yang Y
    Oncologist; 2019 Feb; 24(Suppl 1):S21-S30. PubMed ID: 30819828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immuno-checkpoint inhibitor resistance and strategy in lung cancer].
    Jiang WR; Fang LP; Chang N; Zhang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jul; 43(7):603-606. PubMed ID: 32629564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estrogen pathway as a modulator of response to immunotherapy.
    Velez MA; Burns TF; Stabile LP
    Immunotherapy; 2019 Sep; 11(13):1161-1176. PubMed ID: 31361169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of Immunotherapy in Non-Small Cell Lung Cancer.
    Hsu ML; Naidoo J
    Thorac Surg Clin; 2020 May; 30(2):187-198. PubMed ID: 32327177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in evidence-based medicine for immunotherapy of non-small cell lung cancer.
    Dong J; Li B; Zhou Q; Huang D
    J Evid Based Med; 2018 Nov; 11(4):278-287. PubMed ID: 30444051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?
    Cetin B; Bilgetekin İ; Ozet A
    Curr Probl Cancer; 2019 Feb; 43(1):43-53. PubMed ID: 30104030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.
    Socinski MA
    Semin Oncol; 2015 Oct; 42 Suppl 2():S1-2. PubMed ID: 26477469
    [No Abstract]   [Full Text] [Related]  

  • 12. Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer?
    Patel JD; Chmura SJ
    Cancer; 2018 Jul; 124(14):2878-2880. PubMed ID: 29906817
    [No Abstract]   [Full Text] [Related]  

  • 13. KEYNOTE-024: Unlocking a pathway to lung cancer cure?
    Rusch VW; Chaft J; Hellmann M
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1777-1780. PubMed ID: 29395215
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biomarkers predictive of PD1/PD-L1 immunotherapy in non-small cell lung cancer].
    Lupo A; Alifano M; Wislez M; Boulle G; Velut Y; Biton J; Cremer I; Goldwasser F; Leroy K; Damotte D
    Rev Pneumol Clin; 2018 Oct; 74(5):339-350. PubMed ID: 30337201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer.
    Awada G; Klastersky J
    Curr Opin Oncol; 2018 Mar; 30(2):98-104. PubMed ID: 29303787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy combinations emerging in non-small-cell lung cancer.
    Chao YL; Pecot CV
    Immunotherapy; 2018 Jun; 10(8):627-629. PubMed ID: 29882690
    [No Abstract]   [Full Text] [Related]  

  • 17. Finally, after decades, immune checkpoint inhibitors dethroned the standard of care of small-cell lung cancer.
    Saleh K; Khalife-Saleh N; Kourie HR
    Immunotherapy; 2019 Apr; 11(6):457-460. PubMed ID: 30860440
    [No Abstract]   [Full Text] [Related]  

  • 18. There and back again: An immunotherapy tale.
    Guo Y; Krupnick AS
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1771-1774. PubMed ID: 29409610
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-small-cell lung cancer: what are the benefits and challenges of treating it with immune checkpoint inhibitors?
    Rassy E; Mezquita L; Remon J; Besse B
    Immunotherapy; 2019 Sep; 11(13):1149-1160. PubMed ID: 31361172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of immunotherapy in locally advanced non-small cell lung cancer].
    Levy A; Doyen J; Botticella A; Bourdais R; Achkar S; Giraud P; Du C; Naltet C; Lavaud P; Besse B; Pradère P; Mercier O; Caramella C; Planchard D; Deutsch E; Le Péchoux C
    Cancer Radiother; 2020 Feb; 24(1):67-72. PubMed ID: 32037126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.